PharmaShots | Incisive News in 3 Shots

Subscribe Now

chronic rhinosinusitis

GSK's Nucala (mepolizumab) Receives the US FDA's Approval for the Treatment of Chronic Rhinosinusitis with Nasal Polyps

GSK's Nucala (mepolizumab) Receives the US FDA's Approval for the Treatment of Chronic Rhinosinusitis with Nasal Polyps

July 30, 2021

Sanofi's Dupixent (dupilumab) Receives the Health Canada Approval for Severe Chronic Rhinosinusitis with Nasal Polyposis

Sanofi's Dupixent (dupilumab) Receives the Health Canada Approval for Severe Chronic Rhinosinusitis with Nasal Polyposis

August 19, 2020

Regeneron and Sanofi's Dupixent (dupilumab) Receives FDA's Approval for Chronic Rhinosinusitis with Nasal Polyposis

Regeneron and Sanofi's Dupixent (dupilumab) Receives FDA's Approval for Chronic Rhinosinusitis with Nasal Polyposis

June 27, 2019

Regeneron's Dupixent (Dupilumab) Achieves 1EP & 2EP in two P-III trial for Inadequately-Controlled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Regeneron's Dupixent (Dupilumab) Achieves 1EP & 2EP in two P-III trial for Inadequately-Controlled Chronic Rhinosinusitis with...

October 16, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us